-
Posts
8,079 -
Joined
-
Last visited
-
Days Won
553
MaryO's Achievements
Single Status Update
-
Relacorilant, an investigational therapy developed by Corcept Therapeutics, may effectively manage the effects of excess cortisol in patients with Cushing’s syndrome, interim data from an ongoing Phase 2 trial show.
In particular, the treatment significantly improved sugar tolerance and the levels of osteocalcin, a bone growth biomarker commonly suppressed by excess cortisol.
Read more at https://cushieblog.com/2018/05/12/relacorilant-effectively-manages-cortisol-effects-in-cushings-patients/